文献速递产科母胎医学

血液IGFBP-1检测对羊水栓塞诊断的价值:回顾性多中心队列研究

Contribution of blood detection of insulin-like growth factor binding protein-1 for the diagnosis of amniotic-fluid embolism: a retrospective multicentre cohort study.
PubMed 文献 · BJOG · 2021-03-17

法国三家三级产科单位回顾性分析86例疑似羊水栓塞并检测母血清IGFBP-1的病例,比较生物学与临床诊断一致性。按UKOSS标准,IGFBP-1诊断羊水栓塞灵敏度16%、特异度88%,临床与实验室诊断一致性仅轻微(Cohen's Kappa 0.04)。结论质疑血液IGFBP-1用于日常临床早期诊断羊水栓塞的实用性。

要点

  • IGFBP-1诊断羊水栓塞灵敏度仅16%,特异度88%,阳性预测值58%,阴性预测值50%。
  • 临床与实验室诊断一致性轻微,Cohen's Kappa系数为0.04。
  • 采用SMFM更结构化定义未实质改变结果,不支持IGFBP-1用于早期诊断。

核心结论

  • 研究结果质疑血液IGFBP-1检测在日常临床实践中用于羊水栓塞早期诊断的实用性。

研究设计与样本

  • 回顾性多中心队列研究,纳入法国三家三级产科单位2011至2019年间86例疑似羊水栓塞并完成母血清IGFBP-1检测的妇女数据。

主要发现

  • 临床与实验室诊断羊水栓塞一致性轻微,Cohen's Kappa系数为0.04。
  • 按UKOSS标准,血液IGFBP-1诊断羊水栓塞灵敏度16%、特异度88%,阳性似然比1.3、阴性似然比0.95,阳性预测值58%、阴性预测值50%。
  • 采用SMFM更结构化定义未实质改变结果。

关键数值与推荐

  • 以UKOSS标准作为羊水栓塞回顾性诊断主要终点,SMFM定义作为次要终点。
  • UKOSS标准下IGFBP-1灵敏度16%、特异度88%、阳性似然比1.3、阴性似然比0.95、阳性预测值58%、阴性预测值50%。

临床怎么用

  • 不建议将血液IGFBP-1检测作为日常临床早期诊断羊水栓塞的可靠依据。

局限性

  • 回顾性多中心队列设计,样本量86例,仅纳入完成IGFBP-1检测的疑似病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the contribution of maternal blood detection of IGFBP-1 for the diagnosis of amniotic-fluid embolism in clinical daily practice. DESIGN: A retrospective multicentre cohort study. SETTING: Three tertiary care obstetric units in France. SAMPLE: Data of 86 women for whom amniotic-fluid embolism had been suspected and maternal serum detection of IGFBP-1 had been performed between 2011 and 2019 were analysed. METHODS: The criteria defined by the United Kingdom Obstetric Surveillance System (UKOSS) were used for the retrospective diagnosis of amniotic-fluid embolism. The more structured definition proposed by the Society for Maternal-Fetal Medicine and the Amniotic Fluid Embolism Foundation (SMFM) was also used as secondary endpoint. MAIN OUTCOME MEASURES: Agreements between biological and clinical assessments were tested. The performance of blood detection of IGFBP-1 for the diagnosis of amniotic-fluid embolism according to the UKOSS criteria, and to the SMFM definition, was also assessed. RESULTS: There was only slight agreement between clinical and laboratory diagnosis of amniotic-fluid embolism (Cohen's Kappa coefficient: 0.04). Blood detection of IGFBP-1 had a sensitivity of 16%, a specificity of 88%, a positive and a negative likelihood ratio of 1.3 and 0.95, respectively, and a positive and a negative predictive value of 58 and 50%, respectively, for the diagnosis of amniotic-fluid embolism based on the UKOSS criteria. The use of the more structured SMFM definition of amniotic-fluid embolism did not substantially change the results. CONCLUSION: These results question the usefulness of blood detection of IGFBP-1 for the early diagnosis of amniotic-fluid embolism in daily clinical practice. TWEETABLE ABSTRACT: This retrospective multicentre study questions the contribution of IGFBP-1 detection for the diagnosis of AFE.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Bouvet L, Gariel C, Charvet A, et al. Contribution of blood detection of insulin-like growth factor binding protein-1 for the diagnosis of amniotic-fluid embolism: a retrospective multicentre cohort study. BJOG. 2021. PMID: 33595867. doi:10.1111/1471-0528.16672

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。